EFTA00020447.pdf
- Type
- pdf
- Source set
- data-set-8
Original source
Extracted text
From: '
(USANYS)"
To:
(USANYE)"
Cc:
(USANYS)"
Subject: RE: Johnny Contreras — Investigation of Jeffrey Epstein Death
Date: Tue, 03 Sep 2019 19:05:23 +0000
Importance: Normal
Of course. Thanks.
From:
(USANYE) <
Sent: Tuesday, September 3, 2019 3:03 PM
To:
(USANYS)
Cc:
(USANYS) <M
>
Subject: Re: Johnny Contreras — Investigation of Jeffrey Epstein Death
Thank you! I'm out of the office til Thursday, is it ok if I give you a call then?
Sent from my iPhone
On Sep 3, 2019, at 1:46 PM,
(USANYS) <
> wrote:
Meeting with Contreras went fine today, feel free to give me a call for more color. The agent's going to write a 302, so
we will forward that when it's final. Thanks again!
From:
(USANYE) <
Sent: Monday, August 26, 2019 4:06 PM
To:
(USANYS)
Cc:
(USANYS)<
I>
Subject: RE: Johnny Contreras — Investigation of Jeffrey Epstein Death
Thanks for letting me know,
And yes, confirmed that we don't need to be there for this. I know you guys are
steering clear of the MS-13 stuff.
If you wouldn't mind just giving me a copy of the notes or the 302 from the proffer, I'd appreciate it, only because Andy
is certain to reference this in his mitigation submission to us/Dal.
Thanks, and good luck!
From:
(USANYS)
Sent: Monday, August 26, 2019 4:01 PM
To:
(USANYE) <
Cc:
(USANYS) <E
>
Subject: RE: Johnny Contreras — Investigation of Jeffrey Epstein Death
Fii
FYI, we are meeting with Contreras on 9/3 at 1 SA. Andy preferred not to have a proffer agreement. I know we
discussed this, but can you confirm that no one from your side wanted to be there? Thanks again.
EFTA00020447
From:
(USANYS)
Sent: Tuesday, August 20, 2019 4:59 PM
To:
(USANYE)
Cc:
(USANYS)
Subject: RE: Johnny Contreras — Investigation of Jeffrey Epstein Death
Thanks! If you're good with it, we'll reach out, copying you, to set up a proffer within the next week or so. Copying
who's also working on this.
From:
(USANYE) c>
Sent: Tuesday, August 20, 2019 4:46 PM
To:
(US…
Open in the interactive archive →